About Anifera
Anifera is a company based in United Kingdom founded in 2020. The company has 4 employees as of October 31, 2021. Anifera operates in a competitive market with competitors including Peptobiotics, Proteon Pharmaceuticals, NovoBind Livestock Therapeutics, Carus Laboratories and Ponni Symbiologicals, among others.
- Headquarter United Kingdom
- Employees 4 as on 31 Oct, 2021
-
Sectors
Agriculture
-
Phone
*********
-
Website
*********
- Legal Name Anifera Limited
- Date of Incorporation 29 Sep, 2020
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
4
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Anifera
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Seed - Anifera | Valuation |
investors |
Investors in Anifera
Anifera has secured backing from 1 investor. Prominent investors backing the company include Centre for Innovation Excellence in Livestock (CIEL).
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anifera
Financial Statements - Anifera
Anifera Comparisons
Competitors of Anifera
Anifera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Peptobiotics, Proteon Pharmaceuticals, NovoBind Livestock Therapeutics, Carus Laboratories and Ponni Symbiologicals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptides-based livestock feed additives are manufactured for animal nutrition.
|
|
| domain | founded_year | HQ Location |
Therapeutics for animal infectious diseases are developed via phage platforms.
|
|
| domain | founded_year | HQ Location |
Manufacturer and supplier of biological products for animal health protection
|
|
| domain | founded_year | HQ Location |
Provides comprehensive solutions for veterinary feed supplements.
|
|
| domain | founded_year | HQ Location |
Provides pharmaceutical products tailored for poultry farmers.
|
Latest news on Anifera
Frequently Asked Questions about Anifera
Anifera was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Anifera is headquartered in United Kingdom.
Gwynneth Thomas is the current CEO of Anifera.
As of Oct 31, 2021, the latest employee count at Anifera is 4.
Anifera was founded in 2020 in the United Kingdom. Solutions for antibiotic detection and control in livestock are developed within the agricultural biotechnology sector. A bacterial protection mechanism is utilized to reduce antibiotic overuse. Antibiotic activity is enhanced, biofilms are disrupted and prevented, and bacterial resistance is mitigated as part of the core operations. Services focus on livestock health management across relevant geographies.
Anifera's top competitors include Proteon Pharmaceuticals, NovoBind Livestock Therapeutics and Peptobiotics.
Anifera has 1 investor. Key investors include Centre for Innovation Excellence in Livestock (CIEL).